Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome

Objective. Kisspeptin 1 might reflect increased androgen level in polycystic ovarian syndrome instead of other markers. Study Design. A case control study was performed in Al-Yarmouk Teaching Hospital from 1st of July 2016 to 1st of July 2017; it involved 87 women divided into two groups: 44 women d...

Full description

Saved in:
Bibliographic Details
Main Authors: Manal Madany Abdalqader, Shatha Sami Hussein
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Obstetrics and Gynecology International
Online Access:http://dx.doi.org/10.1155/2020/5216903
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849473271067574272
author Manal Madany Abdalqader
Shatha Sami Hussein
author_facet Manal Madany Abdalqader
Shatha Sami Hussein
author_sort Manal Madany Abdalqader
collection DOAJ
description Objective. Kisspeptin 1 might reflect increased androgen level in polycystic ovarian syndrome instead of other markers. Study Design. A case control study was performed in Al-Yarmouk Teaching Hospital from 1st of July 2016 to 1st of July 2017; it involved 87 women divided into two groups: 44 women diagnosed as PCOS, 22 women with BMI ≥ 25 kg/m2 and 22 women with BMI < 25 kg/m2, and another 43 women without PCOS, 22 women with BMI ≥ 25 kg/m2 and 21 women with BMI < 25 kg/m2. Hormonal, metabolic profiles, and hirsutism scores, as well as serum kisspeptin level, were assessed by using Human Kisspeptin 1(KISS-1) ELISA Kit. The blood samples between days 2 and 5 of menstrual cycle were drawn by an disposable sterile syringe and collected in EDTA containing tubes (as anticoagulant), and the hormonal profile was measured using a biotech ELISA reader. Result. Serum level of kisspeptin was significantly higher in PCOS compared to control (322.4 vs. 235.3 ng/L, respectively). There was no significant difference in age, BMI, and parity between control and PCOS; the frequency of hirsutism, acne, elevated LH, and increased free testosterone (fTT) were significantly higher in PCOS compared to control. Kisspeptin shows a direct significant correlation with hirsutism and fTT (r = 0.648, 0.238, respectively). In ROC analysis, kisspeptin had AUC (95% CI) = 0.874 (0.785–0.935) for predicting PCOS. Conclusion. Kisspeptin levels might be used as a marker for hyperandrogenemia in polycystic ovarian syndrome.
format Article
id doaj-art-d344f3b991b34c8e8b9bb977d0ba4777
institution Kabale University
issn 1687-9589
1687-9597
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Obstetrics and Gynecology International
spelling doaj-art-d344f3b991b34c8e8b9bb977d0ba47772025-08-20T03:24:12ZengWileyObstetrics and Gynecology International1687-95891687-95972020-01-01202010.1155/2020/52169035216903Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary SyndromeManal Madany Abdalqader0Shatha Sami Hussein1College of Medicine, Department of Obstetrics &Gynecology, Al-Mustansiriyah University, Baghdad, IraqCollege of Medicine, Department of Obstetrics &Gynecology, Al-Mustansiriyah University, Baghdad, IraqObjective. Kisspeptin 1 might reflect increased androgen level in polycystic ovarian syndrome instead of other markers. Study Design. A case control study was performed in Al-Yarmouk Teaching Hospital from 1st of July 2016 to 1st of July 2017; it involved 87 women divided into two groups: 44 women diagnosed as PCOS, 22 women with BMI ≥ 25 kg/m2 and 22 women with BMI < 25 kg/m2, and another 43 women without PCOS, 22 women with BMI ≥ 25 kg/m2 and 21 women with BMI < 25 kg/m2. Hormonal, metabolic profiles, and hirsutism scores, as well as serum kisspeptin level, were assessed by using Human Kisspeptin 1(KISS-1) ELISA Kit. The blood samples between days 2 and 5 of menstrual cycle were drawn by an disposable sterile syringe and collected in EDTA containing tubes (as anticoagulant), and the hormonal profile was measured using a biotech ELISA reader. Result. Serum level of kisspeptin was significantly higher in PCOS compared to control (322.4 vs. 235.3 ng/L, respectively). There was no significant difference in age, BMI, and parity between control and PCOS; the frequency of hirsutism, acne, elevated LH, and increased free testosterone (fTT) were significantly higher in PCOS compared to control. Kisspeptin shows a direct significant correlation with hirsutism and fTT (r = 0.648, 0.238, respectively). In ROC analysis, kisspeptin had AUC (95% CI) = 0.874 (0.785–0.935) for predicting PCOS. Conclusion. Kisspeptin levels might be used as a marker for hyperandrogenemia in polycystic ovarian syndrome.http://dx.doi.org/10.1155/2020/5216903
spellingShingle Manal Madany Abdalqader
Shatha Sami Hussein
Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome
Obstetrics and Gynecology International
title Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome
title_full Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome
title_fullStr Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome
title_full_unstemmed Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome
title_short Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome
title_sort metastatin as a marker for hyperandrogenemia in iraqi women with polycystic ovary syndrome
url http://dx.doi.org/10.1155/2020/5216903
work_keys_str_mv AT manalmadanyabdalqader metastatinasamarkerforhyperandrogenemiainiraqiwomenwithpolycysticovarysyndrome
AT shathasamihussein metastatinasamarkerforhyperandrogenemiainiraqiwomenwithpolycysticovarysyndrome